Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

Abstract

Hypertension may predict outcome of bevacizumab-containing chemotherapy in mCRC. These data require confirmation in prospective studies including pharmacodynamic and pharmacokinetic analyses.